Protalix BioTherapeutics, Inc.
USD2.33
-0.02 (-0.85%)
CEO
Dror Bashan
IPO Date
1998-05-15
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$2.33
Prev. Close
$2.35
Day Low
$2.31
Day High
$2.36
52W Low
$1.36
52W High
$3.19
Market Cap
$0.19B
Volume
0.32M
| 46.5 |
| 31 Dec 2023 | FY | 64.9% | 12.7% | 24.8% | 9.8% | 0.82 | 1.54 | 14.5 |
| 31 Dec 2022 | FY | 58.9% | -31.3% | 140.3% | -26.8% | -3.15 | 1.38 | -4.4 |
| 31 Dec 2021 | FY | 57.4% | -71.9% | 457.0% | -37.4% | -5.55 | 1.86 | -1.3 |
| 31 Dec 2020 | FY | 82.7% | -10.4% | 24.1% | -9.6% | -2.38 | 0.64 | -16.2 |
| 31 Dec 2019 | FY | 80.1% | -33.4% | 26.0% | -40.3% | -0.87 | 0.81 | -2.7 |
| 31 Dec 2018 | FY | 72.8% | -77.3% | 50.0% | -43.3% | -0.91 | 2.09 | -1.7 |
| 31 Dec 2017 | FY | 27.7% | -395.9% | 266.6% | -115.5% | -1.67 | 2.75 | -1.0 |
| 31 Dec 2016 | FY | 8.7% | -319.2% | 294.9% | -35.7% | -7.79 | 1.09 | -15.4 |
| -6.4 |
| 30 Sept 2025 | Q3 | 53.4% | 13.2% | 4.5% | 2.9% | 0.15 | 3.03 | 18.7 |
| 30 Jun 2025 | Q2 | 62.5% | 1.0% | 0.3% | 0.2% | 0.11 | 2.72 | 177.5 |
| 31 Mar 2025 | Q1 | 19.1% | -35.8% | -8.0% | -4.9% | 0.12 | 2.49 | -13.5 |
| 31 Dec 2024 | Q4 | 78.7% | 35.6% | 15.0% | 8.8% | 0.13 | 2.34 | 5.3 |
| 30 Sept 2024 | Q3 | 53.4% | 18.0% | 10.0% | 5.3% | 0.18 | 1.98 | 5.8 |
| 30 Jun 2024 | Q2 | 29.8% | -16.4% | -7.7% | -2.4% | 0.97 | 1.33 | -9.7 |
| 31 Mar 2024 | Q1 | 30.6% | -122.6% | -15.4% | -5.1% | 0.89 | 1.38 | -5.0 |
| 31 Dec 2023 | Q4 | 15.5% | -57.6% | -18.0% | -7.2% | 0.78 | 1.54 | -5.4 |